scholarly journals Relationship between Hemoglobin A1c Level and Flow‐mediated Vasodilation in Patients with Type 2 Diabetes Mellitus Receiving Antidiabetic Drugs

2021 ◽  
Author(s):  
Takayuki Yamaji ◽  
Takahiro Harada ◽  
Yu Hashimoto ◽  
Yukiko Nakano ◽  
Masato Kajikawa ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Hemoglobin A1c ◽  
Antidiabetic Drugs ◽  
Flow Mediated Vasodilation

Smoking, Hemoglobin A1c and Complications in People with Type 2 Diabetes Mellitus

2015 ◽  
Vol 10 (01) ◽  
pp. 10-15
Author(s):  
Nampeth Saibuathong ◽  
Nareemarn Neelapaichit
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Hemoglobin A1c

Relationship between preoperative hemoglobin A1c levels and long-term mortality after coronary artery bypass grafting in patients with type 2 diabetes mellitus

2016 ◽  
Vol 202 ◽  
pp. 291-296 ◽  
Author(s):  
Jeanette Kuhl ◽  
Ulrik Sartipy ◽  
Björn Eliasson ◽  
Thomas Nyström ◽  
Martin J. Holzmann
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Hemoglobin A1c ◽  
Artery Bypass ◽  
Bypass Grafting ◽  
Preoperative Hemoglobin ◽  
Long Term Mortality

scholarly journals Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: The Diabetes & Aging Study

2017 ◽  
Vol 31 (1) ◽  
pp. 94-100 ◽  
Author(s):  
Neda Laiteerapong ◽  
Andrew J. Karter ◽  
Howard H. Moffet ◽  
Jennifer M. Cooper ◽  
Robert D. Gibbons ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Hemoglobin A1c ◽  
Aging Study

scholarly journals Effect of Antihyperglycemic Agents on Hemoglobin A1c Level in Type 2 Diabetes Mellitus Patients

2018 ◽  
Vol 5 (2) ◽  
pp. 57-63
Author(s):  
Tasya Kamila ◽  
Vycke Yunivita Kusumah Dewi ◽  
Miftahurachman Miftahurachman
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Hemoglobin A1c ◽  
Antihyperglycemic Agents

scholarly journals Cost-effectiveness study of antidiabetic drugs in type 2 diabetes mellitus patients from Mumbai, India

2017 ◽  
Vol 4 (9) ◽  
pp. 3180 ◽  
Author(s):  
Dnyanesh Limaye ◽  
Krishna Todi ◽  
Jay Shroff ◽  
Ashutosh Ramaswamy ◽  
Priyanka Kulkarni ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Cross Sectional Study ◽  
Antidiabetic Drugs ◽  
Cross Sectional ◽  
Validated Questionnaire ◽  
The Cost

Background: Diabetes is fast gaining the status of a potential epidemic in India, with >62 million individuals currently diagnosed with the disease. India currently faces an uncertain future in relation to the potential burden that diabetes may impose on the country. An estimated US$ 2.2 billion would be needed to sufficiently treat all cases of type 2 diabetes mellitus (T2DM) in India. Many interventions can reduce the burden of this disease. However, health care resources are limited; thus, interventions for diabetes treatment should be prioritized. The present study assesses the cost-effectiveness of antidiabetic drugs in patients with T2DM from Mumbai, India.Methods: A prospective cross-sectional study was performed to assess the cost-effectiveness of antidiabetic drugs in patients with T2DM. Face-to-face interviews were conducted by using a validated questionnaire in a total of 152 (76 males, 76 females) patients with T2DM from F-North Ward, Mumbai, India. Cost-effectiveness was determined on the basis of cost of antidiabetic drug/s, efficacy, adverse drug reactions, safety of administration, frequency of administration, and bioavailability. Results: For treatment of T2DM in non-obese participants, Glimepiride+Pioglitazone costed least (`3.7) per unit of effectiveness followed by Glimepiride (`6.6), Gliclazide (`8.1), Repaglinide (`24.5), and Vildagliptin (`45.2). For treatment of T2DM in obese participants, Metformin cost least (` 6.7) per unit of effectiveness followed by Glimepiride + Metformin (`5.9) and Repaglinide (`24.5). Conclusions: In case of non-obese participants, cost effectiveness and prescribed treatments did not show a match, while for obese participants prescribed treatments were in line with cost effectiveness. 

Effect of Individual Versus Group Diabetes Outpatient Education on Weight Change, Hemoglobin A1c and Lipid Values in Adults with Type 2 Diabetes Mellitus

2007 ◽  
Vol 107 (8) ◽  
pp. A40 ◽  
Author(s):  
L.M. Vero ◽  
M. Wien ◽  
L. Byham-Gray ◽  
R. Touger-Decker ◽  
J. O’Sullivan Maillet
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Weight Change ◽  
Hemoglobin A1c ◽  
Versus Group
Sign in / Sign up

Export Citation Format

Share Document